Jon Blaskovich
Chief Tech/Sci/R&D Officer bij BIOHAVEN PHARMACEUTICAL HOLDING COMPANY LTD.
Profiel
Mr. Jon Blaskovich is Directeur-Informatietechnologie bij Biohaven Pharmaceutical Holding Co. Ltd. Hij behaalde zijn doctoraal aan het Rochester Institute of Technology.
Actieve functies van Jon Blaskovich
| Bedrijven | Functie | Begin |
|---|---|---|
| BIOHAVEN PHARMACEUTICAL HOLDING COMPANY LTD. | Chief Tech/Sci/R&D Officer | - |
| BIOHAVEN LTD. | Chief Tech/Sci/R&D Officer | - |
Eerdere bekende functies van Jon Blaskovich
| Bedrijven | Functie | Einde |
|---|---|---|
Epsilon Data Management LLC
 Epsilon Data Management LLC Advertising/Marketing ServicesCommercial Services Epsilon Data Management LLC provides marketing and data management services. It offers multi channel marketing, technologies and database solutions, strategic consulting, and account management services. The company was founded in 1969 and is headquartered in Irving, TX. | Chief Tech/Sci/R&D Officer | - |
Opleiding van Jon Blaskovich
| Rochester Institute of Technology | Undergraduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| BIOHAVEN LTD. | Health Technology |
| Bedrijven in privébezit | 2 |
|---|---|
Epsilon Data Management LLC
Epsilon Data Management LLC Advertising/Marketing ServicesCommercial Services Epsilon Data Management LLC provides marketing and data management services. It offers multi channel marketing, technologies and database solutions, strategic consulting, and account management services. The company was founded in 1969 and is headquartered in Irving, TX. | Commercial Services |
Biohaven Pharmaceutical Holding Co. Ltd.
 Biohaven Pharmaceutical Holding Co. Ltd. Pharmaceuticals: MajorHealth Technology Biohaven Pharmaceutical Holding Co. Ltd. is a clinical-stage biopharmaceutical company, which engages in the research and development of late-stage product candidates targeting neurological diseases, including rare disorders. It focuses on a pipeline of product candidates that represent mechanistic platforms, calcitonin gene-related peptide receptor antagonists, and glutamate modulators. The company was founded in September 2013 and is headquartered in New Haven, CT. | Health Technology |
